Arzerra

Medicinal product

(Invented) name

Arzerra

Active substance (s)

Ofatumumabas

Strength

1000 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FA02, Ofatumumab

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2010-04-19

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	50 ml
Ofatumumabas	1000 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
45736	59538	1059538	flakonas	N1		Receptinis	EU/1/10/625/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-02-27	Išregistruotas
2010-04-19	Registruotas